In addition, cancer survivors exposed to both cardiotoxic and so-called “non-cardiotoxic” drugs had a higher mean body mass index, higher fasting serum non-high-density-lipoprotein, higher insulin levels, and higher sensitivity C-reactive protein levels, suggesting that all cancer survivors exposed to any type of cancer therapy had a high risk of CTRCD (20). Here, INS is linked to cancer.